(Q51534830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Deleterious effects of indomethacin in the mid-gestation human intestine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Nancy Perron

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Eric Tremblay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Corentin Babakissa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ernest G Seidman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Emile Levy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Daniel Ménard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Jean-François Beaulieu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

20 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

171-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23261704%20AND%20SRC:MED&resulttype=core&format=json

Management of the neonate with patent ductus arteriosus

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Indomethacin in pregnancy: applications and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Pulmonary arterial hypertension in congenital heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Treatment of patent ductus arteriosus: indomethacin or ibuprofen?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

The risk of necrotizing enterocolitis after indomethacin tocolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Gastroduodenal Safety of Cyclooxygenase-2 Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Management of NSAID-related gastrointestinal mucosal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Intestinal permeability in the pathogenesis of NSAID-induced enteropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Indomethacin-induced mitochondrial dysfunction and oxidative stress in villus enterocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Indomethacin-induced translocation of bacteria across enteric epithelia is reactive oxygen species-dependent and reduced by vitamin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Explant culture of human fetal small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Human fetal colon in organ culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Anti-inflammatory effects of epidermal growth factor on the immature human intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Gene expression profiles of normal proliferating and differentiating human intestinal epithelial cells: a comparison with the Caco-2 cell model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Gene-expression profile analysis in the mid-gestation human intestine discloses greater functional immaturity of the colon as compared with the ileum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

In vitro effects of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation in rat liver mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Glucose and citrate reduce the permeability changes caused by indomethacin in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

CYP3A gene expression in human gut epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Oxidative innate immune defenses by Nox/Duox family NADPH oxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Inhibition of inducible nitric oxide synthase delays gastric ulcer healing in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a novel approach for reducing gastrointestinal toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Superoxide dismutases: role in redox signaling, vascular function, and diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Epidermal growth factor receptor signaling modulates chemokine (CXC) ligand 5 expression and is associated with villus angiogenesis after small bowel resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003

A new mathematical model for relative quantification in real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.12.003